Role of Deficient Mismatch Repair in the Personalized Management of Colorectal Cancer

Colorectal cancer (CRC) represents the third most common type of cancer in developed countries and one of the leading causes of cancer deaths worldwide. Personalized management of CRC has gained increasing attention since there are large inter-individual variations in the prognosis and response to d...

Full description

Bibliographic Details
Main Authors: Cong-Min Zhang, Jin-Feng Lv, Liang Gong, Lin-Yu Yu, Xiao-Ping Chen, Hong-Hao Zhou, Lan Fan
Format: Article
Language:English
Published: MDPI AG 2016-09-01
Series:International Journal of Environmental Research and Public Health
Subjects:
Online Access:http://www.mdpi.com/1660-4601/13/9/892
id doaj-ec21315b60844fa0a36177adac33884a
record_format Article
spelling doaj-ec21315b60844fa0a36177adac33884a2020-11-25T01:02:16ZengMDPI AGInternational Journal of Environmental Research and Public Health1660-46012016-09-0113989210.3390/ijerph13090892ijerph13090892Role of Deficient Mismatch Repair in the Personalized Management of Colorectal CancerCong-Min Zhang0Jin-Feng Lv1Liang Gong2Lin-Yu Yu3Xiao-Ping Chen4Hong-Hao Zhou5Lan Fan6Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, ChinaDepartment of Pharmacy, Xiangya Hospital, Central South University, Changsha 410008, ChinaDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, ChinaDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, ChinaDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, ChinaDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, ChinaDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, ChinaColorectal cancer (CRC) represents the third most common type of cancer in developed countries and one of the leading causes of cancer deaths worldwide. Personalized management of CRC has gained increasing attention since there are large inter-individual variations in the prognosis and response to drugs used to treat CRC owing to molecular heterogeneity. Approximately 15% of CRCs are caused by deficient mismatch repair (dMMR) characterized by microsatellite instability (MSI) phenotype. The present review is aimed at highlighting the role of MMR status in informing prognosis and personalized treatment of CRC including adjuvant chemotherapy, targeted therapy, and immune checkpoint inhibitor therapy to guide the individualized therapy of CRC.http://www.mdpi.com/1660-4601/13/9/892colorectal cancerpersonalized treatmentmismatch repair systemmicrosatellite instabilityadjuvant chemotherapytargeted therapyimmune checkpoint inhibitor therapy
collection DOAJ
language English
format Article
sources DOAJ
author Cong-Min Zhang
Jin-Feng Lv
Liang Gong
Lin-Yu Yu
Xiao-Ping Chen
Hong-Hao Zhou
Lan Fan
spellingShingle Cong-Min Zhang
Jin-Feng Lv
Liang Gong
Lin-Yu Yu
Xiao-Ping Chen
Hong-Hao Zhou
Lan Fan
Role of Deficient Mismatch Repair in the Personalized Management of Colorectal Cancer
International Journal of Environmental Research and Public Health
colorectal cancer
personalized treatment
mismatch repair system
microsatellite instability
adjuvant chemotherapy
targeted therapy
immune checkpoint inhibitor therapy
author_facet Cong-Min Zhang
Jin-Feng Lv
Liang Gong
Lin-Yu Yu
Xiao-Ping Chen
Hong-Hao Zhou
Lan Fan
author_sort Cong-Min Zhang
title Role of Deficient Mismatch Repair in the Personalized Management of Colorectal Cancer
title_short Role of Deficient Mismatch Repair in the Personalized Management of Colorectal Cancer
title_full Role of Deficient Mismatch Repair in the Personalized Management of Colorectal Cancer
title_fullStr Role of Deficient Mismatch Repair in the Personalized Management of Colorectal Cancer
title_full_unstemmed Role of Deficient Mismatch Repair in the Personalized Management of Colorectal Cancer
title_sort role of deficient mismatch repair in the personalized management of colorectal cancer
publisher MDPI AG
series International Journal of Environmental Research and Public Health
issn 1660-4601
publishDate 2016-09-01
description Colorectal cancer (CRC) represents the third most common type of cancer in developed countries and one of the leading causes of cancer deaths worldwide. Personalized management of CRC has gained increasing attention since there are large inter-individual variations in the prognosis and response to drugs used to treat CRC owing to molecular heterogeneity. Approximately 15% of CRCs are caused by deficient mismatch repair (dMMR) characterized by microsatellite instability (MSI) phenotype. The present review is aimed at highlighting the role of MMR status in informing prognosis and personalized treatment of CRC including adjuvant chemotherapy, targeted therapy, and immune checkpoint inhibitor therapy to guide the individualized therapy of CRC.
topic colorectal cancer
personalized treatment
mismatch repair system
microsatellite instability
adjuvant chemotherapy
targeted therapy
immune checkpoint inhibitor therapy
url http://www.mdpi.com/1660-4601/13/9/892
work_keys_str_mv AT congminzhang roleofdeficientmismatchrepairinthepersonalizedmanagementofcolorectalcancer
AT jinfenglv roleofdeficientmismatchrepairinthepersonalizedmanagementofcolorectalcancer
AT lianggong roleofdeficientmismatchrepairinthepersonalizedmanagementofcolorectalcancer
AT linyuyu roleofdeficientmismatchrepairinthepersonalizedmanagementofcolorectalcancer
AT xiaopingchen roleofdeficientmismatchrepairinthepersonalizedmanagementofcolorectalcancer
AT honghaozhou roleofdeficientmismatchrepairinthepersonalizedmanagementofcolorectalcancer
AT lanfan roleofdeficientmismatchrepairinthepersonalizedmanagementofcolorectalcancer
_version_ 1725205715290685440